Research Article
Revisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit
Table 2
Type of referral for 2019 only.
| | | Routine | Urgent | Urgent suspected cancer | Private health clinic referral | Emergency referral | Screening detected | Others | Not known | Total | | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
| | Total | 191 (8.2) | 209 (9) | 995 (42.9) | 33 (1.4) | 444 (19.2) | 150 (6.5) | 152 (6.6) | 144 (6.2) | 2318 | | Sex | | Male | 120 (10.6) | 101 (8.9) | 490 (43.2) | 21 (1.9) | 214 (18.9) | 37 (3.3) | 85 (7.5) | 65 (5.7) | 1133 | | Female | 71 (6.0) | 108 (9.1) | 505 (42.6) | 12 (1) | 230 (19.4) | 113 (9.5) | 67 (5.7) | 79 (6.7) | 1185 | | Age categories (years) | | 0–24 | <5 | <5 | 7 (26.9) | <5 | 11 (42.3) | 0 (0) | <5 | <5 | 26 | | 25–49 | 20 (9.5) | 16 (7.6) | 104 (49.5) | 11 (5.2) | 34 (16.2) | 8 (3.8) | 9 (4.3) | 8 (3.8) | 210 | | 50–64 | 42 (6.9) | 59 (9.7) | 274 (45.2) | 9 (1.5) | 83 (13.7) | 72 (11.9) | 30 (5) | 37 (6.1) | 606 | | 65–74 | 72 (10.1) | 62 (8.7) | 313 (43.8) | 7 (1) | 112 (15.7) | 58 (8.1) | 47 (6.6) | 44 (6.2) | 715 | | 75–84 | 45 (7.9) | 49 (8.6) | 241 (42.3) | <5 | 135 (23.7) | 12 (2.1) | 43 (7.5) | 41 (7.2) | 570 | | ≥85 | 10 (5.2) | 21 (11) | 56 (29.3) | <5 | 69 (36.1) | 0 (0) | 22 (11.5) | 12 (6.3) | 191 | | Cancer site categories | | Bladder | 5 (8.5) | 6 (10.2) | 26 (44.1) | <5 | 13 (22) | 0 (0) | <5 | <5 | 59 | | Brain | 6 (16.2) | <5 | <5 | <5 | 25 (67.6) | 0 (0) | 0 (0) | <5 | 37 | | Breast | 13 (4.4) | 20 (6.7) | 158 (53.2) | 8 (2.7) | 16 (5.4) | 67 (22.6) | <5 | 12 (4) | 297 | | Colon | 12 (5.1) | 29 (12.3) | 79 (33.6) | 0 (0) | 49 (20.9) | 48 (20.4) | <5 | 15 (6.4) | 235 | | Gynae–others | 6 (6.0) | 14 (14) | 60 (60) | 0 (0) | 7 (7) | 8 (8) | <5 | <5 | 100 | | Leukaemia | <5 | <5 | 8 (17.4) | 0 (0) | 22 (47.8) | 0 (0) | 6 (13) | 5 (10.9) | 46 | | Liver and bile tract | 5 (9.1) | <5 | 14 (25.5) | 0 (0) | 21 (38.2) | <5 | 10 (18.2) | <5 | 55 | | Lung and bronchus | 14 (3.8) | 29 (7.8) | 132 (35.6) | 0 (0) | 113 (30.5) | <5 | 47 (12.7) | 35 (9.4) | 371 | | Lymphoma | 9 (8.9) | 10 (9.9) | 41 (40.6) | 6 (5.9) | 22 (21.8) | 0 (0) | 8 (7.9) | 5 (5) | 101 | | Melanoma | 19 (16.2) | 11 (9.4) | 71 (60.7) | <5 | 0 (0) | <5 | 12 (10.3) | <5 | 117 | | Multiple myeloma | <5 | <5 | 5 (16.7) | 0 (0) | 15 (50) | <5 | <5 | <5 | 30 | | Oesophageal | <5 | 8 (12.9) | 37 (59.7) | 0 (0) | 10 (16.1) | <5 | <5 | <5 | 62 | | Oral/oropharyngeal | <5 | 8 (11.1) | 37 (51.4) | <5 | <5 | 0 (0) | <5 | 18 (25) | 72 | | Others | 11 (9.8) | 12 (10.7) | 43 (38.4) | 5 (4.5) | 24 (21.4) | <5 | 9 (8) | 7 (6.3) | 112 | | Ovarian | <5 | <5 | 27 (60) | 0 (0) | 11 (24.4) | 0 (0) | <5 | <5 | 45 | | Pancreas | <5 | <5 | 12 (23.5) | <5 | 26 (51) | <5 | <5 | <5 | 51 | | Prostate | 55 (19.1) | 26 (9) | 155 (53.8) | 5 (1.7) | 19 (6.6) | <5 | 18 (6.3) | 7 (2.4) | 288 | | Rectal | 9 (9.8) | 9 (9.8) | 41 (44.6) | <5 | <5 | 16 (17.4) | <5 | 7 (7.6) | 92 | | Renal | 9 (12.7) | 8 (11.3) | 22 (31) | <5 | 19 (26.8) | <5 | 9 (12.7) | <5 | 71 | | Stomach and small intestine | <5 | 5 (7.4) | 26 (38.2) | <5 | 24 (35.3) | 0 (0) | <5 | 5 (7.4) | 68 | | Unknown primary | 0 (0.0) | <5 | 0 (0) | 0 (0) | <5 | 0 (0) | <5 | <5 | 9 | | Patient SIMD1 | | 1 | 30 (6.6) | 40 (8.8) | 176 (38.5) | <5 | 102 (22.3) | 31 (6.8) | 39 (8.5) | 38 (8.3) | 457 | | 2 | 34 (7.6) | 38 (8.5) | 190 (42.5) | <5 | 92 (20.6) | 31 (6.9) | 30 (6.7) | 30 (6.7) | 447 | | 3 | 47 (10.6) | 49 (11.1) | 190 (42.9) | 6 (1.4) | 83 (18.7) | 23 (5.2) | 16 (3.6) | 29 (6.5) | 443 | | 4 | 33 (7.7) | 43 (10) | 191 (44.6) | 8 (1.9) | 68 (15.9) | 31 (7.2) | 32 (7.5) | 22 (5.1) | 428 | | 5 | 47 (8.9) | 38 (7.2) | 242 (46) | 15 (2.9) | 96 (18.3) | 32 (6.1) | 33 (6.3) | 23 (4.4) | 526 | | 2-fold urban rural classification2 | | Urban | 148 (8.2) | 166 (9.2) | 759 (41.9) | 20 (1.1) | 359 (19.8) | 122 (6.7) | 117 (6.5) | 119 (6.6) | 1810 | | Rural | 42 (8.7) | 42 (8.7) | 228 (47) | 12 (2.5) | 81 (16.7) | 26 (5.4) | 33 (6.8) | 21 (4.3) | 485 | | Comorbidities3 | | None | 46 (7.7) | 51 (8.6) | 284 (47.7) | 17 (2.9) | 90 (15.1) | 54 (9.1) | 18 (3) | 35 (5.9) | 595 | | 1 | 59 (8.6) | 59 (8.6) | 317 (45.9) | 8 (1.2) | 115 (16.7) | 51 (7.4) | 42 (6.1) | 39 (5.7) | 690 | | 2 | 43 (8.4) | 48 (9.4) | 208 (40.8) | <5 | 112 (22) | 30 (5.9) | 40 (7.8) | 25 (4.9) | 510 | | ≥3 | 42 (8.4) | 51 (10.2) | 176 (35.3) | <5 | 124 (24.9) | 15 (3) | 51 (10.2) | 36 (7.2) | 498 |
|
|
1Not including 17 with unknown SIMD; 2not including 23 with unknown rurality; 3not including 25 with unknown comorbidity.
|
